The promise of cardiomyocyte computational models for drug safety

Lei Wang; Blanca Rodriguez

doi:10.1186/s40779-025-00675-3

Your Location：

Home >

Browse articles >

The promise of cardiomyocyte computational models for drug safety

LETTER TO THE EDITOR | Updated：2026-01-29

- The promise of cardiomyocyte computational models for drug safety
- “In the field of xxx, expert xx has made significant research progress. By establishing the xx system/exploring the xx topic/verifying the xx conjecture, xx has provided solutions to address xx problems/open up a new direction for xx research/lay a foundation for the construction of the xx system.”
- Military Medical Research Vol. 12, (2025)
- Affiliations：
  
  1.Beijing National Center for Applied Mathematics, Capital Normal University, Beijing 100048, China
  2.Department of Computer Science, University of Oxford, Oxford OX1 3QD, UK
- Author bio：
  
  * Lei Wang lei.wang@cnu.edu.cn
- Funds：
- DOI：10.1186/s40779-025-00675-3
  CLC：
- Received：28 August 2025，
  
  Accepted：20 November 2025，
  
  Online First：05 December 2025，
  
  Published：2025
- Accepted：
Scan QR Code
Lei Wang, Blanca Rodriguez. The promise of cardiomyocyte computational models for drug safety[J/OL]. Military Medical Research, 2025, 12.
DOI：

Lei Wang, Blanca Rodriguez. The promise of cardiomyocyte computational models for drug safety[J/OL]. Military Medical Research, 2025, 12. DOI： 10.1186/s40779-025-00675-3.

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Leveraging artificial intelligence for clinical decision support in personalized standard regimen recommendation for cancer

Artificial intelligence in orthopedics:fundamentals, current applications, and future perspectives

Unresolved questions in the application of artificial intelligence virtual cells for cancer research

Artificial intelligence in digital pathology diagnosis and analysis: technologies,challenges, and future prospects

Integrating artificial intelligence with human reasoning in oncology: questions on real-world implementation and patient-centric evidence

Related Author

Ning Li

Shu-Hang Wang

Ya-Le Jiang

Guo Zhao

Jian Song

Guang-Chao Wang

Si-Cheng Wang

Chong-Ru He

Related Institution

Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Orthopedics, Trauma Orthopedics Center, Institute of Musculoskeletal Injury and Translational Medicine of Organoids, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Department of Orthopedics, Shanghai Zhongye Hospital

Department of Orthopedics, Orthopedic Research Institution of Hebei Province, NHC Key Laboratory of Intelligent Orthopedic Equipment, The Third Hospital of Hebei Medical University

Institute of Translational Medicine, Organoid Research Center, National Center for Translational Medicine (Shanghai), Shanghai University Branch

⁰

The promise of cardiomyocyte computational models for drug safety

DOI：10.1186/s40779-025-00675-3